Patience and Consistency Pay Off: While results can vary, most Aspire MedSpa clients begin to see meaningful changes within the first three months, with continued benefits as treatment progresses
M., Gregg, E
Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome: A Bridge between Functional Organic Dichotomy
Even at 1 mg weekly, most users report noticeable appetite suppression and reduced food noise
The medicine may also be good for people with fatty liver disease
2024 Meta-Analysis Indicates That GLP-1RAs Reduce Adverse CV Events A 2024 Meta-analysis of 13 multiple cardiovascular outcome trials has documented that GLP1-RA therapy significantly reduces the risk of major adverse cardiovascular events (MACEs), all-cause mortality, CV mortality, stroke, risk for coronary revascularization, and composite adverse kidney outcomes in both sexes, regardless of a patient's history of cardiovascular disease, BMI or eGFR (Rivera et al, 2024)